Christopher J. Twomey - Jun 11, 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Director
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Jun 11, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/12/2025, 04:51 PM
Previous filing: May 23, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
TWOMEY CHRISTOPHER J	Director	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO	/s/ Jonathan V. Dixon, Attorney-in-Fact	2025-06-12	0001238935

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+2.78K		$0.00	2.78K	Jun 11, 2025	Common Stock	2.78K	$3.67	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

Content

The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).